MedTech Spectrum

Article Name Predictive Diagnostics

OrthAlign introduces Lantern handheld technology for knee arthroplasty in Japan

For Total, Partial, and Revision Knee Arthroplasty

14th May, 2024

US based C₂N Diagnostics expands Alzheimer’s diagnostics into Japan

Expands into Japan through Mediford Corporation partnership with Precivity blood testing for Alzheimer’s Disease and brain research market

30th April, 2024

Neuberg Diagnostics forms JV with Sehgal Path Lab to expand haemato-oncology segment

The collaboration will see Sehgal Path Lab rebranded as Neuberg Sehgal Path Lab

29th April, 2024

Owlstone Medical secures $6.5 M to develop breath-based diagnostics for infectious disease

Developing new cost-effective detection technologies for volatile organic compounds (VOCs)

25th April, 2024

Serum Institute of India partners with Univercells to make personalised cancer treatments more accessible

The therapies can reach patients in Europe, India and the African continent

12th April, 2024

IIT Jodhpur develops framework for smartphones-assisted glucose testing device

Allowing diagnostic information to easily be available straight on the phone by simply using an app

28th March, 2024

Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo

Cognizant's AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors

20th March, 2024

Vygon spearheads neonatal safety in India with groundbreaking Nutrisafe2 system

First company in the country to launch the enhanced neonatal feeding system

18th March, 2024

Johnson & Johnson Innovation names finalists in atopic advancements QuickPitch

Johnson & Johnson QuickPitch finalists revealed in atopic advancements

13th March, 2024

Bowtie and the Chinese University of Hong Kong Hospital join hands to launch "medical insurance + health" package

Bowtie and CUHK Hospital Unveil Innovative Medical Insurance + Health Package

11th March, 2024

“Early diagnosis through advanced screening tech, coupled with heightened awareness is crucial”

The oncology market in India is steadily growing, driven by an increasing cancer incidence and a strong demand for advanced treatments. However, there remains substantial untapped potential, primarily in improving access to cutting-edge therapies and expanding reach to underserved regions. Glenmark Pharma, with its patient-centric approach and innovative solutions, has been steadily increasing its market share by introducing high-quality and affordable cancer drugs. Alok Malik, President & Business Head - India Formulations, Glenmark Pharmaceuticals Ltd, in an exclusive interview with MedTech Spectrum & BioSpectrum, spoke at length about the company’s mission to enhance access to high-quality cancer care in India and the untapped market potential, new launches and the plans ahead.

28th February, 2024

MicroPort® CRM Advances Heart Failure Treatment in Japan with Launch of GALI™ SonR® CRT-D and NAVIGO™ 4LV Leads

GALI™ SonR® CRT-D and NAVIGO™ 4LV Pacing Leads Launch Set to Enhance Heart Failure Management and Patient Safety

19th February, 2024

NeoLacta Life Sciences makes significant Impact, Touching lives of 1 Lakh preterm infants in India

Transforming the Lives of 1 Lakh Preterm Infants in India through Innovative Healthcare Solutions

30th January, 2024

3D Printing Our Way to the Future of MedTech

Care is becoming more personalized. Innovation cycles are growing shorter and shorter. Healthcare companies are increasingly looking for ways to eliminate waste and complexity. These are only a few of the reasons why 3D printing has become such an invaluable tool for MedTech research and design teams. 3D printing can make the impractical a reality. It can help providers customize devices to meet the unique care needs of individual patients almost immediately. It’s now even possible to 3D print medicine and simulated body parts.

30th January, 2024

Singapore's Mechanobiology Institute Secures S$49 Million for Advancing Biomedical Innovations

The National University of Singapore's Mechanobiology Institute (MBI) has recently secured a substantial S$49 million funding boost from the National Research Foundation (NRF) to propel advancements in mechanobiology. This funding, spread over seven years starting from December 2023, will be instrumental in conducting research to address age-related loss of biomechanical functions, particularly focusing on ailments such as infertility, chronic inflammatory diseases, muscle atrophy, and cancer.

29th January, 2024

BD Advances Women's Health Equity in Kenya with Cancer Screening

Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer Rates

26th January, 2024

Biomedical Innovation: Answer for Climate-sensitive Diseases

The world is finally paying attention to the impact of climate change on neglected diseases. What we need now is medical innovation.

08th January, 2024

“The Open Innovation Program has become a trend in the molecular diagnostics industry”

Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins. With a mission for a disease-free world and proactive pandemic prevention, Seegene seamlessly integrates high multiplex diagnostic assays with automated testing systems. In an interaction with BioSpectrum & MedTech Spectrum, Dr Seong-Youl Kim, Seegene's Senior Vice President, shares insights on the company, the molecular diagnostics landscape, challenges and opportunities etc.

08th January, 2024